Actavis forecasts 2012 sales in excess of 2 billion euros
Linkedin

Actavis forecasts 2012 sales in excess of 2 billion euros

Frankfurt : Germany | Oct 19, 2012 at 12:05 AM PDT
Source: Turks and Caicos Free Press
XX XX
Views: Pending
 
Actavis , the Swiss generic drugmaker that Watson Pharmaceuticals is taking over, said revenue would rise to more than 2 billion euros ($2.6 billion) this year, driven by patent expiries in Europe and strong demand in the United States . Sales would increase by a double-digit percentage rate in 2012,... FULL ARTICLE AT Turks and Caicos Free Press
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
 
Advertisement
 
Advertisement
 

More From Allvoices

 
Tap_logo_330_110_event
 


Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc 2008-2013. All rights reserved.